Quality of Recovery After Reversal With Neostigmine or Sugammadex.
Clinical trial NCT02909439 · COMPLETED
Trial details
- NCT number
- NCT02909439
- Sponsor
- Stony Brook University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-11-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.